Treatment of Systemic Inflammatory Response Syndrome (SIRS)

Source Control and Initial Management

The World Journal of Emergency Surgery recommends source control as essential in managing SIRS, particularly when caused by intra-abdominal infections or other identifiable sources 1
Early recognition of SIRS is crucial for effective treatment, with prompt administration of empiric broad-spectrum antibiotics when infection is suspected, as recommended by the World Journal of Emergency Surgery 1
Judicious intravenous fluid resuscitation should be initiated and titrated based on clinical response rather than predetermined protocols, according to the World Journal of Emergency Surgery 1
Vasopressor agents may be necessary to augment fluid resuscitation in patients with hemodynamic instability, as stated by the World Journal of Emergency Surgery 1
Delay in providing adequate source control has been associated with adverse outcomes including death in SIRS with intra-abdominal sepsis, as reported by the World Journal of Emergency Surgery 1

The Infectious Diseases Society of America recommends antibiotic therapy for patients with SIRS when infection is suspected or confirmed 2
Antibiotics should be initiated promptly in patients with SIRS and signs of organ failure such as hypotension, oliguria, or decreased mental alertness, as recommended by the World Journal of Emergency Surgery 3
Empiric broad-spectrum antibiotic coverage should be started while awaiting culture results, according to the World Journal of Emergency Surgery 1
For SIRS associated with skin and soft tissue infections, antibiotic selection should be guided by likely pathogens and local resistance patterns, as recommended by the Infectious Diseases Society of America 2

The American College of Rheumatology recommends a stepwise approach to immunomodulatory treatment for SIRS associated with MIS-C (Multisystem Inflammatory Syndrome in Children) 5, 6
Intravenous immunoglobulin (IVIG) and/or glucocorticoids are considered first-tier agents for SIRS related to MIS-C, as recommended by the American College of Rheumatology 5, 6
IVIG at a dose of 2 gm/kg based on ideal body weight is recommended for MIS-C patients requiring hospitalization, according to the American College of Rheumatology 6
Low-to-moderate dose glucocorticoids (1-2 mg/kg/day) should be used as adjunctive therapy with IVIG in patients with shock and/or organ-threatening disease, as recommended by the American College of Rheumatology 6

For SIRS with coagulopathy, vitamin K (5-10 mg subcutaneously) should be administered, but correction with fresh frozen plasma is only indicated for invasive procedures or profound coagulopathy, as recommended by the American Association for the Study of Liver Diseases 7
Surveillance for infection is necessary in SIRS patients, with periodic cultures of sputum, urine, and blood for fungal and bacterial organisms, according to the American Association for the Study of Liver Diseases 7
Prophylactic antibiotics and anti-fungals may be considered in high-risk SIRS patients but have not been definitively shown to improve overall outcomes, as stated by the American Association for the Study of Liver Diseases 7

Serial laboratory testing and cardiac assessment should guide the immunomodulatory treatment response and tapering in SIRS associated with MIS-C, as recommended by the American College of Rheumatology 8
Patients with SIRS may require a 2-3 week taper of immunomodulatory medications, according to the American College of Rheumatology 8
For SIRS with cardiac involvement, electrical conduction abnormalities should be monitored with EKGs at minimum every 48 hours in hospitalized patients, as recommended by the American College of Rheumatology 9
Sequential monitoring of inflammation markers is recommended to assess response to therapy, according to the American College of Rheumatology 5

In patients with SIRS and septic shock, invasive source control may need to proceed even during ongoing resuscitation if the patient is at risk of death, as recommended by the World Journal of Emergency Surgery 1
Probiotics have been studied in critically ill patients with SIRS but evidence for their routine use remains limited, as reported by the Society of Critical Care Medicine 10

Delaying source control measures while waiting for patient stabilization can worsen outcomes in severe SIRS, as reported by the World Journal of Emergency Surgery 1
Overuse of antibiotics in SIRS without confirmed infection can contribute to antimicrobial resistance, as stated by the Infectious Diseases Society of America 2